COSCIENS Biopharma Inc. (CSCIF)

OTCMKTS · Delayed Price · Currency is USD
1.750
-0.130 (-6.91%)
At close: Feb 26, 2026
-35.19%
Market Cap 5.70M
Revenue (ttm) 9.05M
Net Income (ttm) -14.91M
Shares Out n/a
EPS (ttm) -4.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 265
Average Volume 1,289
Open 1.880
Previous Close 1.880
Day's Range 1.750 - 1.880
52-Week Range 1.700 - 4.605
Beta n/a
RSI 32.85
Earnings Date Mar 25, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 40
Stock Exchange OTCMKTS
Ticker Symbol CSCIF
Full Company Profile

Financial Performance

In 2024, COSCIENS Biopharma's revenue was $9.59 million, an increase of 34.22% compared to the previous year's $7.14 million. Losses were -$15.31 million, 339.3% more than in 2023.

Financial Statements

News

There is no news available yet.